NMR or BAC: Which Is the Better Value Stock Right Now?

Core Viewpoint - Nomura Holdings (NMR) is currently viewed as a better value opportunity compared to Bank of America (BAC) based on various valuation metrics and earnings outlook [1][7]. Valuation Metrics - NMR has a forward P/E ratio of 8.67, significantly lower than BAC's forward P/E of 11.93 [5]. - The PEG ratio for NMR is 0.30, indicating a more favorable valuation relative to its expected EPS growth compared to BAC's PEG ratio of 1.19 [5]. - NMR's P/B ratio stands at 0.81, while BAC's P/B ratio is higher at 1.24, suggesting that NMR is undervalued in terms of market value versus book value [6]. Earnings Outlook - NMR is experiencing an improving earnings outlook, which enhances its attractiveness in the Zacks Rank model, indicating a positive trend in earnings estimates [3][7]. - The Zacks Rank for NMR is 2 (Buy), while BAC holds a Zacks Rank of 3 (Hold), reflecting a stronger earnings estimate revision for NMR [3].